Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)
This study has been withdrawn prior to enrollment.
( slow enrollment )
Study NCT00372723   Information provided by Loyola University

First Received on September 5, 2006.   Last Updated on April 25, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Toxic Epidermal Necrolysis
Additional conditions recognized in this trial
Epidermal Necrolysis, Toxic
Staphylococcal Scalded Skin Syndrome
More general conditions related to this trial
Bacterial Infections
Dermatitis
Drug Eruptions
Drug Hypersensitivity
Drug Toxicity
Gram-Positive Bacterial Infections
Hypersensitivity
Immune System Diseases
Infection
Poisoning
Skin Diseases
Skin Diseases, Bacterial
Skin Diseases, Infectious
Staphylococcal Infections
Staphylococcal Skin Infections
Substance-Related Disorders
Interventions listed in this trial
Remicaide (infliximab)
Additional drug interventions recognized in this trial
Infliximab
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antirheumatic Agents
Dermatologic Agents
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Loyola University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services